Alemtuzumab/cladribineAutoimmune thyroid disorder and alopecia areata universalis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1898卷 / 1期

关键词：

D O I：

10.1007/s40278-022-11622-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：29 / 29

相关论文

共 50 条

[21] Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
Ferreira, Sineida Berbert
Scheinberg, Morton
Steiner, Denise
Steiner, Tatiana
Bedin, Gustavo Longhi
Ferreira, Rachel Berbert
CASE REPORTS IN DERMATOLOGY, 2016, 8 (03): : 262 - 266
[22] Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
Kolcz, Kinga
Zychowska, Magdalena
Sawinska, Edyta
Reich, Adam
DERMATOLOGY AND THERAPY, 2023, 13 (03) : 843 - 856
[23] Alemtuzumab/prednisoneBacteraemia: 2 case reports
Reactions Weekly, 2020, 1802 (1) : 25 - 25
[24] Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
Forouzan, Parnia
Cohen, Philip R.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
[25] AlemtuzumabAlopecia areata: 2 case reports
Reactions Weekly, 2019, 1734 (1) : 30 - 30
[26] ZonisamideAlopecia areata: 2 case reports
Reactions Weekly, 2007, 1178 (1) : 35 - 35
[27] MethylphenidateAlopecia areata: 2 case reports
Reactions Weekly, 2018, 1683 (1) : 454 - 454
[28] UstekinumabAlopecia areata: 2 case reports
Reactions Weekly, 2012, 1420 (1) : 48 - 48
[29] UstekinumabAlopecia areata: 2 case reports
Reactions Weekly, 2014, 1492 (1) : 42 - 42
[30] GolimumabAlopecia areata: 2 case reports
Reactions Weekly, 2017, 1668 (1) : 195 - 195

← 1 2 3 4 5 →